183 related articles for article (PubMed ID: 26692876)
21. The relationship between the first episode of wheezing and matrix metalloproteinases-9 and MMP-2 and tissue inhibitors of MMP-1 levels in preterm infants.
Sezer RG; Aydemir G; Bozaykut A; Hira S; Tanju IA; Ozcan O
Ann Thorac Med; 2013 Oct; 8(4):209-13. PubMed ID: 24250734
[TBL] [Abstract][Full Text] [Related]
22. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
23. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
Chen X; Li H; Qiu X; Yang C; Walther FJ
BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
[TBL] [Abstract][Full Text] [Related]
24. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.
Morrow LA; Wagner BD; Ingram DA; Poindexter BB; Schibler K; Cotten CM; Dagle J; Sontag MK; Mourani PM; Abman SH
Am J Respir Crit Care Med; 2017 Aug; 196(3):364-374. PubMed ID: 28249118
[TBL] [Abstract][Full Text] [Related]
25. Predictive and Diagnostic Values of Systemic Inflammatory Indices in Bronchopulmonary Dysplasia.
Cao L; Liu X; Sun T; Zhang Y; Bao T; Cheng H; Tian Z
Children (Basel); 2023 Dec; 11(1):. PubMed ID: 38255338
[TBL] [Abstract][Full Text] [Related]
26. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors.
Kiciński P; Kęsiak M; Nowiczewski M; Gulczyńska E
Pol Merkur Lekarski; 2017 Feb; 42(248):71-75. PubMed ID: 28258680
[TBL] [Abstract][Full Text] [Related]
27. Relationship between bronchopulmonary dysplasia, long-term lung function, and vitamin D level at birth in preterm infants.
Lu T; Liang B; Jia Y; Cai J; Wang D; Liu M; He B; Wang Q
Transl Pediatr; 2021 Nov; 10(11):3075-3081. PubMed ID: 34976773
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
[No Abstract] [Full Text] [Related]
29. Mean platelet volume and risk of bronchopulmonary dysplasia and intraventricular hemorrhage in extremely preterm infants.
Dani C; Poggi C; Barp J; Berti E; Fontanelli G
Am J Perinatol; 2011 Aug; 28(7):551-6. PubMed ID: 21404166
[TBL] [Abstract][Full Text] [Related]
30. Bronchopulmonary Dysplasia Is Associated with Altered Brain Volumes and White Matter Microstructure in Preterm Infants.
Lee JM; Choi YH; Hong J; Kim NY; Kim EB; Lim JS; Kim JD; Park HK; Lee HJ
Neonatology; 2019; 116(2):163-170. PubMed ID: 31112968
[TBL] [Abstract][Full Text] [Related]
31. Hypertensive Disorders during Pregnancy and Risk of Bronchopulmonary Dysplasia in Very Preterm Infants.
Rocha GM; de Lima FF; Machado AP; Guimarães HA;
Am J Perinatol; 2019 Jan; 36(2):176-183. PubMed ID: 29996153
[TBL] [Abstract][Full Text] [Related]
32. Investigating the expression of MMPs and TIMPs in preterm placenta and role of CpG methylation in regulating MMP-9 expression.
Sundrani D; Narang A; Mehendale S; Joshi S; Chavan-Gautam P
IUBMB Life; 2017 Dec; 69(12):985-993. PubMed ID: 29130646
[TBL] [Abstract][Full Text] [Related]
33. Biomarker Potential of the Soluble Receptor for Advanced Glycation End Products to Predict Bronchopulmonary Dysplasia in Premature Newborns.
Go H; Ohto H; Nollet KE; Sato K; Miyazaki K; Maeda H; Ichikawa H; Chishiki M; Kashiwabara N; Kume Y; Ogasawara K; Sato M; Hosoya M
Front Pediatr; 2021; 9():649526. PubMed ID: 33996692
[TBL] [Abstract][Full Text] [Related]
34. [Association between serum 25(OH)D levels at birth and bronchopulmonary dysplasia in preterm infants].
Yu RQ; Chen DZ; Zhou Q; Wang M; Mei YZ; Jiang SY
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Oct; 19(10):1051-1055. PubMed ID: 29046199
[TBL] [Abstract][Full Text] [Related]
35. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response.
Kasahara A; Hayashi N; Mochizuki K; Oshita M; Katayama K; Kato M; Masuzawa M; Yoshihara H; Naito M; Miyamoto T; Inoue A; Asai A; Hijioka T; Fusamoto H; Kamada T
J Hepatol; 1997 Mar; 26(3):574-83. PubMed ID: 9075665
[TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants.
Mohamed WA; Niyazy WH; Mahfouz AA
J Trop Pediatr; 2011 Oct; 57(5):385-8. PubMed ID: 21131270
[TBL] [Abstract][Full Text] [Related]
37. The Correlation Between Bronchopulmonary Dysplasia and Platelet Metabolism in Preterm Infants.
Yan L; Ren Z; Wang J; Xia X; Yang L; Miao J; Xu F; Gao W; Yang J
Front Pediatr; 2021; 9():670469. PubMed ID: 34900853
[No Abstract] [Full Text] [Related]
38. N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker of Bronchopulmonary Dysplasia or Death in Preterm Infants: A Retrospective Cohort Analysis.
Zhou L; Xiang X; Wang L; Chen X; Zhu J; Xia H
Front Pediatr; 2019; 7():166. PubMed ID: 31134166
[No Abstract] [Full Text] [Related]
39. Severity of bronchopulmonary dysplasia and increased risk of feeding desaturation and growth delay in very low birth weight preterm infants.
Wang LY; Luo HJ; Hsieh WS; Hsu CH; Hsu HC; Chen PS; Chiu NC; Lee WT; Jeng SF
Pediatr Pulmonol; 2010 Feb; 45(2):165-73. PubMed ID: 20054861
[TBL] [Abstract][Full Text] [Related]
40. Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia.
Vento G; Tirone C; Lulli P; Capoluongo E; Ameglio F; Lozzi S; Cota F; Mosca F; Romagnoli C; Messana I; Castagnola M; Inzitari R
Intensive Care Med; 2009 Dec; 35(12):2115-24. PubMed ID: 19779697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
